| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Staphylococcus aureus (strain MRSA252) Gamma-hemolysin component C |
|---|
| Description | 30-315aa; Full Length. MW: 48.59kD. Purity >90% as determined by SDS-PAGE. Toxin that seems to act by forming pores in the membrane of the cell. Has a hemolytic and a leucotoxic activity |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.1 mg (E-Coli), 0.2 mg (E-Coli), 0.5 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Staphylococcus aureus (strain MRSA252)] |
|---|
| Gene, Accession, CAS # | hlgC, Accession: WP_000916697.1 |
|---|
| Catalog # | MBS969728 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Staphylococcus aureus (strain MRSA252) Gamma-hemolysin component C from MYBIOSOURCE INC. |
|---|
| Product Specific References | Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance.Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J., Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A., Bason N., Bentley S.D., Chillingworth C., Chillingworth T., Churcher C., Clark L., Corton C. Parkhill J.Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004) |
|---|
| 产品资料 |
|
|